3American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med , 2000, 161:221 -247
4Centers for Disease Control and Prevention. Controlling tuberculosis in the United States :recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR,2005,54 : 1 - 81
5Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med, 2004,350:2060 - 2067
6Haley CA, Cain KP, Yu C, et al. Risk-based screening for latent tuberculosis infection. Southern Med J, 2008, 101 : 142 - 149
7Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis. MMWR, 2000, 49:1-54
8Ozekinci T, Ozbek E. Comparison of tuberculin skin test and a specific T-cell-based test, T-Spot. TB, for the diagnosis of latent tuberculosis infection. J Int Med Res, 2007, 35:696 - 703
9Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest, 2007, 131:1898 - 1906
10Mazurek GH, Jereb J, Lobue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep, 2005, 54:49 - 55
